← SynDRA
BAY-1217389
SynDRA canonical compound SYN0039879 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | TTK |
|---|
| Mechanism of action | kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- TTK INHIBITOR
- Dual specificity protein kinase TTK inhibitor
- kinase inhibitor
Cross-references
Synonyms
- BAY 1217389
- 8RH
- BAY 12-17389
- BAY1217389
- CPD 79
- M964LB1114
- UNII-M964LB1114
- compound 35 [PMID: 31121430]
- compound 35 (PMID: 31121430)
- RefChem:116722
- MFCD30502614
- WNEILUNVMHVMPH-UHFFFAOYSA-N
- orb1695455
- SCHEMBL15555839
- SCHEMBL30381937
- GTPL12705
- EX-A948
- C27H24F5N5O3
- BDBM258444
- GLXC-10350
- EMC45853
- EBC-84115
- NSC787026
- s8215
- AKOS032944938
- CCG-265387
- CS-6182
- NSC-787026
- BAY1217389?
- AC-36064
- DA-50965
- HY-12859
- MS-30193
- US9512130, 2
Look up BAY-1217389 in the interactive SynDRA portal →